Shareholders of E-Z-EM of Lake Success, NY, have approved the company's proposed acquisition by Italian contrast firm Bracco of Milan.
Under the terms of the agreement, stockholders will receive $21 per share in cash, making the transaction worth approximately $241 million. The deal is expected to close on or about April 1, pending the satisfaction or waiver of all the closing conditions in the agreement.
E-Z-EM would become part of Bracco's U.S.-based subsidiary, Bracco Diagnostics of Princeton, NJ.
Related Reading
Bracco to acquire E-Z-EM, October 30, 2007
Road to RSNA, MRI. E-Z-EM, October 29, 2007
Road to RSNA, CT, E-Z-EM, October 22, 2007
E-Z-EM sales dip in Q1, October 11, 2007
Bracco inks deal with HealthTrust, October 8, 2007
Copyright © 2008 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
